Catalyst Wire Dossier Catalyst Wire Dossier

rmhTNF

recombinant human tumor necrosis factor (rmhTNF)
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for rmhTNF, covering 2023-03-06 to 2024-07-11. Get the full timeline:

Most recent: Clinical Trial Update: A Real-world Research on the Prevention and Treatment of Peritoneal Metastasis and Malignant Ascites by Intraperitoneal Infusion of rmhTNF in Gastric and Colorectal Malignant Tumors

See pricing